Sanofi Receivables 2012-2026 | SNY

Sanofi receivables for the quarter ending March 31, 2026 were $0.564B, a 19.8% increase year-over-year.

  • Sanofi receivables for 2024 were $9.091B, a 4.81% decline from 2023.
  • Sanofi receivables for 2023 were $9.55B, a 3.03% increase from 2022.
  • Sanofi receivables for 2022 were $9.27B, a 4.22% decline from 2021.

Sanofi Receivables 2012-2026 | SNY

  • Sanofi receivables for 2024 were $9.091B, a 4.81% decline from 2023.
  • Sanofi receivables for 2023 were $9.55B, a 3.03% increase from 2022.
  • Sanofi receivables for 2022 were $9.27B, a 4.22% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B